VDAC1 (Voltage Dependent Anion Channel 1) was shown to play a critical role in promoting cisplatin resistance in ovarian cancer by regulating the HSP70/HK2/VDAC1 signaling pathway. Here, HK2 is linked to ovarian carcinoma.